72.19.Z - Scientific research and development activities
20.59.Z - Manufacture of other chemical products, not elsewhere classified
71.20 - Technical testing and analysis
72.11.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 0 | 4,5 | -3,6 | -179,7 |
EBITDA | 0 | 6,5 | -3,6 | -155 |
Short time liabilities | 0 | 0,4 | 0 | -96,4 |
Equity capital | 0 | 9,5 | 5,9 | -37,8 |
Operating profit (EBIT) | 0 | 6,5 | -3,6 | -155 |
Assets | 0 | 9,9 | 5,9 | -40,1 |
Net profit (loss) | 0 | 4,5 | -3,6 | -179,7 |
Cash | 0 | 4,1 | 0 | -100 |
Liabilities and provisions for liabilities | 0 | 0,4 | 0 | -96,4 |
Net income from sale | 0 | 0,5 | 0 | -100 |
Working assets | 0 | 4,9 | 0,9 | -81 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 47,5 | -60,8 | -108,3 | |
Equity capital to total assets | 96,1 | 99,8 | 3,7 | |
Gross profit margin | 903,4 | |||
EBITDA Margin | 1308 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 280 | 2 147 483 648 | 2 147 483 368 |
Current financial liquidity indicator | 12.762943267822266 | 66.35780334472656 | 53,6 | |
Net dept to EBITDA | -0.6327180862426758 | 0 | 0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane